Respiratory failure associated with pneumocystis pneumonia: A case report

Authors

  • Sunkonkit K Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Thailand
  • Reungrongrat S Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Thailand
  • Chowsilpa S Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand

Keywords:

Pneumocystis jiroveci pneumonia, Acute respiratory failure, Acute respiratory distress syndrome, Child

Abstract

Pneumocystis jiroveci pneumonia (PJP) is a life-threatening condition and a common opportunistic infection that can occur in an immunocompromised host. We report on a case of PJP in a child who had been diagnosed with a brain tumor and underwent who had undergone prior treatment with chemotherapy, dexamethasone an radiation. She presented with progressive dyspnea, hypoxia and acute respiratory failure. Her condition did not improve and developed into acute respiratory distress syndrome (ARDS). Her chest radiograph showed bilateral diffuse alveolar infiltration.Bronchoscopy and bronchoalveolar lavage (BAL) were done and the result was positive for Pneumocystis jiroveci. PJP should be a concern in patients who have risk factors such as prior treatment with corticosteroids, immunosuppressive agents or chemotherapy, patients with hematologic malignancy, HIV infection, primary immune deficiencies or severe malnutrition, and patients who have had a solid-organ transplant.

References

1. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487-98.
2. Thomas CF Jr, Limper AH. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol. 2007;5:298-308.
3. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71:5-13.
4. Crans CA Jr, Boiselle PM. Imaging features of Pneumocystis carinii pneumonia. Crit Rev Diagn Imaging. 1999;40:251-84.
5. Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance. Am Rev Respir Dis. 1988;137:796-800.
6. Limper AH, Offord KP, Smith TF, Martin WJ 2nd. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989;140:1204-9.
7. Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, Catanzaro A, et al. An official American Thoracic society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183:96-128.
8. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med. 1993;119:1198-208.
9. Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma. Int J Radiat Oncol Biol Phys. 1999;44:535-43.

Downloads

Published

2019-07-01

How to Cite

1.
K S, S R, S C. Respiratory failure associated with pneumocystis pneumonia: A case report. BSCM [Internet]. 2019 Jul. 1 [cited 2024 Dec. 23];58(3):171-5. Available from: https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/148684

Issue

Section

Case Report